GE's SnapShot Pulse offers improved dose reduction results for both diagnostic cardiac and neuro perfusion CT exams and ...
March 7, 2008 – CircuLite has advanced its Synergy Pocket Circulatory Assist Device clinical program into a 20-patient trial, after completion of a first-in-man pilot study of Synergy in four patients, as the company seeks CE Mark approval in the European Union for long-term implantation of Synergy in heart failure patients.
March 7, 2008 - Siemens Healthcare launched the DCA Vantage Analyzer, a point-of-care (POC) diabetes patient management ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Siemens Healthcare now has available the DCA Vantage Analyzer, a point-of-care (POC) diabetes patient management ...
March 7, 2008 – KLAS recently named Toshiba’s Aquilion 64, Xario and Vantage 1.5T MR “Best in KLAS” in its Top 20 Year ...
March 5, 2008 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 6, 2008 - The third annual Medical Device Regulatory, Reimbursement and Compliance Congress (Device Congress) to ...
March 6, 2008 - Axellis Ltd., the UK- and US-based medical technology company, has completed acquisitions of three ...
Edwards Lifesciences provides The Vigilance II monitor, which is designed to gives users the ability to present complex ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 4, 2008 – MEDRAD sales revenues grew to $525 million in 2007, an increase of 10 percent over the previous year, which is expected to grow further should the merger with Possis be completed.
For patient monitoring systems not integrated with PiCCO-Technology, Pulsion Medical Systems offers the PiCCO parameters ...
February 5, 2008 - Doctors completed the first implant of Boston Scientific’s COGNIS cardiac resynchronization therapy defibrillator (CRT-D), which reportedly represents an entirely new platform to treat heart failure.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 3, 2008 - Boston Scientific Corp. received CE Mark approval of its ACUITY Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, marking the company�s seventh U.S. or European regulatory approval in the past nine weeks.
March 5, 2008 - Edwards Lifesciences Corp. reported that the first three human implants of the next-generation Edwards transcatheter aortic heart valve were performed at St. Paul's Hospital in Vancouver, British Columbia, marking the progression of minimally-invasive valve therapy.
March 4, 2008 - By using a dual-source technique on a single computed tomography (CT) system, a research team at the ...